Remove Business Remove Data Remove Media Remove Safety
article thumbnail

MyMD Pharmaceuticals Announces New Data from Comparative Study on Lead Compound MYMD-1

Cannabis Law Report

New data shows MYMD-1 has key differentiators and capabilities compared to existing TNF inhibitor drugs. BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Data also demonstrated that none of the biological drugs selected for the comparison study proved to be anti-proliferative to any of the primary cell types assessed.

article thumbnail

Press Release: Delic Announces Medical Advisory Board, Demonstrates Psychedelic Wellness Company’s Commitment to Science

Cannabis Law Report

The Board will advise Delic and its subsidiaries, including Ketamine Infusion Centers, Delic Labs and others, as they develop safety protocols and best practices pertaining to legal psychedelic wellness treatments today and those legalized in the future. Delic is focused on bringing psychedelic wellness to the mainstream.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

IRI Thought Leaders to Discuss New Trends and Research at Several Upcoming Industry Events

Cannabis Law Report

–(BUSINESS WIRE)–IRI: Prepared Foods New Products Conference. . WHAT: During the session, “ Cannabis Moves Toward the Mainstream ,” Nielsen will share IRI and BDSA’s predictions for mainstream market opportunities, cannabis ingredients, product development, labeling and safety. . . WHEN: Sept. 14, 2021, from 11:00 a.m.

Events 78
article thumbnail

Travelers Institute Announces Fall 2021 Virtual Programming

Cannabis Law Report

–(BUSINESS WIRE)–The Travelers Institute , the public policy division of The Travelers Companies, Inc. Our upcoming lineup covers a wide range of topics that are relevant to both individuals and businesses – from politics and new legislation to public health issues, cybersecurity and technology advancements,” said Woodward.

article thumbnail

New- ANH-Intl Special Report: Is safety the new gremlin for CBD regulation?

Cannabis Law Report

We take a look at where CBD regulation might be going and whether we should be concerned about safety writes Rob Verkerk PhD, scientific and executive director, ANH-Intl. We take a look at where CBD regulation might be going and whether we should be concerned about safety. A new ‘problem’: safety. ? A new ‘problem’: safety.

Safety 59
article thumbnail

GemmaCert: Scientific Study Reveals Major Deviation Between Labelled and Actual CBD Potency in Commercial Products

Puff Puff Post

These results raise safety and efficacy concerns. “Ensuring accurate CBD dosage labelling is important for consumer safety and efficacy,” said Dr. Guy Setton , CEO of GemmaCert Ltd. Media Contact: Hadas Weizman hadas@marcomm.co.il +972(0)54-6077622. TEL AVIV, Israel , Feb.

CBD 96
article thumbnail

US Hemp Roundtable Analysis Of FDA CBD Report To Congress

Cannabis Law Report

hemp farmers are denied profitable markets for their crops, while unregulated products continue to proliferate, with no safeguards for public health and safety. With regard to adding CBD to food and beverages, FDA maintains that the data currently available raises safety concerns and encourages parties to share relevant information with FDA.

Hemp 71